Clinical Trial Update: Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ticagrelor versus clopidogrel on endothelial dysfunction and vascular inflammation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Vascular Inflammation

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: Kiyuk Chang | Conditions: Endothelial Dysfunction, Vascular Inflammation | Phase 4 | Status: UNKNOWN